Clinical Trial Update: Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the efficacy and safety of subcutaneous XH-02 for adult hypoparathyroidism; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• XH-02

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hypoparathyroidism | Phase 1, Phase 2 | Status: RECRUITING